Skip to main content

Table 2 Characteristics and prevalence of comorbid conditions in white females

From: Sex-specific responses to mineralocorticoid receptor antagonism in hypertensive African American males and females

Variable

NTN (n = 182)

HTN (n = 490)

HTN + Spiro (n = 12)

Age (year)

51 ± 9

61 ± 9*

58 ± 11*

BMI (kg/m2)

29 ± 7

32 ± 7*

34 ± 5*

SBP (mmHg)

120 ± 13

136 ± 20*

132 ± 24*

HTN medications

0

1.6 ± 0.9*

1.7 ± 0.8*

HTN duration (year)

0

14 ± 12*

22 ± 14*

eGFR (ml/min)

100 ± 8

90 ± 13*

90 ± 11*

Total urinary protein (mg)

2 ± 2

2 ± 4

2 ± 1

Uncontrolled HTN (%)

0

42*

25*

CHD (%)

1

11*

25*

MI (%)

0

5*

0

Stroke (%)

1

3*

8*

Diabetes (%)

3

13*

42*#

  1. NTN normotension, HTN hypertension, HTN + Spiro hypertension with spironolactone treatment, BMI body mass index, HTN hypertension, eGFR estimate glomerular filtration rate, LV left ventricle, CHD coronary heart disease, MI myocardial infarction. *p < 0.05 vs. NTN, #p < 0.05 vs. HTN